Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Regulatory and Legal Considerations with Artificial Intelligence in Dermatology.

PMID: 41093483 · 2025

JournalDermatologic clinics
Year2025
PMID41093483

Abstract

Artificial intelligence (AI) is increasingly being used in dermatology, particularly for image-based diagnostics. However, a number of regulatory and legal challenges remains unanswered. This article reviews the UK regulations for AI-driven medical devices with reference to international comparisons. We have also highlighted some liability concerns with clinical examples to illustrate the complexity. As AI deployment continues to rapidly expand, it is critical that health care practitioners ensu

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.